You Searched For: Cellular+Assays

MycoZap-Inst_INST-LT07-818 All trademarks herein are marks of Lonza Group or its subsidiaries. Developed by Lonza Nottingham Ltd. Page 1 of 2 www.lonza.com U.S. Scientific Support: 800-521-0390 scientific.support@lonza.com EU/ROW Scientific Suppor...

Phenotypic Characterization of Anti-Cancer Drug effects using Automated Imaging | Molecular Devices Benefits • Relevance of compounds identified • Increased drug discovery success and productivity • Translational biomarkers for phenotypic screenin...

Phenotypic Characterization of Anti-Cancer Drug effects using Automated Imaging | Molecular Devices Benefits • Relevance of compounds identified • Increased drug discovery success and productivity • Translational biomarkers for phenotypic screenin...

Phenotypic Characterization of Anti-Cancer Drug effects using Automated Imaging | Molecular Devices Benefits • Relevance of compounds identified • Increased drug discovery success and productivity • Translational biomarkers for phenotypic screenin...

Phenotypic Characterization of Anti-Cancer Drug effects using Automated Imaging | Molecular Devices Benefits • Relevance of compounds identified • Increased drug discovery success and productivity • Translational biomarkers for phenotypic screenin...

Phenotypic Characterization of Anti-Cancer Drug effects using Automated Imaging | Molecular Devices Benefits • Relevance of compounds identified • Increased drug discovery success and productivity • Translational biomarkers for phenotypic screenin...

From Cell to Therapy Solutions for your entire workflow From Research to Production A deep understanding of pathological and therapeutic mechanisms at a cellular and molecular level is key for the discovery and use of drugs. By providing solutions...

MycoZap-Inst_INST-LT07-818 All trademarks herein are marks of Lonza Group or its subsidiaries. Developed by Lonza Nottingham Ltd. Page 1 of 2 www.lonza.com U.S. Scientific Support: 800-521-0390 scientific.support@lonza.com EU/ROW Scientific Suppor...

Phenotypic Characterization of Anti-Cancer Drug effects using Automated Imaging | Molecular Devices Benefits • Relevance of compounds identified • Increased drug discovery success and productivity • Translational biomarkers for phenotypic screenin...

Phenotypic Characterization of Anti-Cancer Drug effects using Automated Imaging | Molecular Devices Benefits • Relevance of compounds identified • Increased drug discovery success and productivity • Translational biomarkers for phenotypic screenin...

Phenotypic Characterization of Anti-Cancer Drug effects using Automated Imaging | Molecular Devices Benefits • Relevance of compounds identified • Increased drug discovery success and productivity • Translational biomarkers for phenotypic screenin...

Phenotypic Characterization of Anti-Cancer Drug effects using Automated Imaging | Molecular Devices Benefits • Relevance of compounds identified • Increased drug discovery success and productivity • Translational biomarkers for phenotypic screenin...

Phenotypic Characterization of Anti-Cancer Drug effects using Automated Imaging | Molecular Devices Benefits • Relevance of compounds identified • Increased drug discovery success and productivity • Translational biomarkers for phenotypic screenin...

Phenotypic Characterization of Anti-Cancer Drug effects using Automated Imaging | Molecular Devices Benefits • Relevance of compounds identified • Increased drug discovery success and productivity • Translational biomarkers for phenotypic screenin...

Phenotypic Characterization of Anti-Cancer Drug effects using Automated Imaging | Molecular Devices Benefits • Relevance of compounds identified • Increased drug discovery success and productivity • Translational biomarkers for phenotypic screenin...

Phenotypic Characterization of Anti-Cancer Drug effects using Automated Imaging | Molecular Devices Benefits • Relevance of compounds identified • Increased drug discovery success and productivity • Translational biomarkers for phenotypic screenin...